StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wells Fargo Downgrades Biogen (BIIB) to Market Perform, Expects Equity to Trade Rang-Bound
March 21, 2019 9:16 AM
Wells Fargo downgraded Biogen (NASDAQ: BIIB) from Outperform to Market Perform.The analyst comments "We expect BIIB to remain range-bound ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
March 25, 2019 7:49 AM
Mizuho Securities Downgrades Biogen (BIIB) to Neutral
March 21, 2019 10:06 AM
Biogen (BIIB) PT Lowered to $275 at Cowen
March 21, 2019 9:20 AM